Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma-Reference-Cited by-同舟云学术

Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma

Published:2020-06-22 Issue:12 Volume:99 Page:2893-2901
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Nagayama Takashi,Ashizawa Masahiro,Ikeda Takashi,Kawaguchi Shin-ichiro,Toda Yumiko,Ito Shoko,Ochi Shin-ichi,Mashima Kiyomi,Umino Kento,Minakata Daisuke,Nakano Hirofumi,Yamasaki Ryoko,Morita Kaoru,Kawasaki Yasufumi,Yamamoto Chihiro,Fujiwara Shin-ichiro,Hatano Kaoru,Sato Kazuya,Oh Iekuni,Ohmine Ken,Muroi Kazuo,Kanda Yoshinobu^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04112-4.pdf

Reference23 articles.

1. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C (2000) Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 18(6):1360–1377

2. Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, Bridger G, Marulkar S, Hsu FJ, DiPersio JF (2011) Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. Biol Blood Marrow Transplant 17(8):1146–1153

3. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 85(2):588–596

4. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86(10):3961–3969

5. Giralt S, Costa L, Schriber J, Dipersio J, Maziarz R, McCarty J, Shaughnessy P, Snyder E, Bensinger W, Copelan E, Hosing C, Negrin R, Petersen FB, Rondelli D, Soiffer R, Leather H, Pazzalia A, Devine S (2014) Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biol Blood Marrow Transplant 20(3):295–308

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation;Annals of Hematology;2024-03-13

2. Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma;Cytotherapy;2023-11

3. Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma;Cancers;2023-01-21

4. Association of CD 34 positive cell dose with engraftment kinetics in autologous peripheral blood stem cell transplant patients of multiple myeloma;Medical Journal Armed Forces India;2021-03